2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…2021 American Transplant Congress
A Case-Match Cohort Comparison of the Safety and Efficacy of Basiliximab for Immunosuppression Holiday in Lung Transplant Patients
1Pharmacy, Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA
*Purpose: Post-transplant complications related to calcineurin inhibitors (CNI) maintenance immunosuppression (MI) may require interim alternative therapies. The goal of this study is to evaluate the…2021 American Transplant Congress
Transplant Data Platform – An Augmented Clinical Intelligence Framework
*Purpose: UNOS, SRTR, USRDS registries are rich in patient baseline data. However, all suffer from data attrition as patients move further out post-transplant or between…2021 American Transplant Congress
Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Data from the US Scientific Registry of Transplant Recipients (SRTR)
*Purpose: There is currently no FDA approved immunosuppressive regimen for lung transplant (Tx) recipients; however, patients routinely receive a calcineurin inhibitor-based regimen. The SRTR database…2021 American Transplant Congress
White, Older Men Are Less Affected by the Changes of the Covid-19 Pandemic
Surgery, Northwestern Medicine, Chicago, IL
*Purpose: This study explores quality of life and lifestyle changes due to the COVID-19 pandemic among pre- and post- liver (LT) and kidney (KT) transplant…2021 American Transplant Congress
Long-Term Renal Outcomes in Lung Transplant Recipients- A Single-Center Five-Year Experience
Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: The increased longevity in Lung transplant (LTx) has led to an upsurge in chronic medical comorbidities, including Acute kidney injury (AKI), Chronic kidney disease…2021 American Transplant Congress
Creating a Lung Transplant Program Search Tool Tailored to Patient Characteristics
*Purpose: Criteria for selecting lung transplant candidates and donors vary between programs and evolve as clinical practice advances. This variation impacts patient outcomes and the…2021 American Transplant Congress
Has the Proportional Rise in Deceased Organ Donation Rate Over Last 5 Years Been Optimal? Data-based, Forecasting Model Analysis of UNOS/NHSBT UK Donor Data
*Purpose: The increase in deceased donor numbers since last decade has been widely reported. We aim to analyse if the trend in rise of numbers…2021 American Transplant Congress
Combined Liver and Lung Transplantation with Extended Normothermic Liver Preservation Using Transmedics Organ Care System (OCS)TM Liver: A Single Center Experience
*Purpose: Combined liver-lung transplantation (CLLT) is indicated in patients who cannot survive single-organ transplantation alone. Ex-situ normothermic machine perfusion (NMP) has been used to increase…2021 American Transplant Congress
Summary of the OPTN’s Policy and System Modifications in Response to the COVID-19 Pandemic
*Purpose: In April 2020, the OPTN made several policy and system modifications in response to the growing COVID-19 pandemic including updates to candidate lab data,…
- « Previous Page
- 1
- …
- 267
- 268
- 269
- 270
- 271
- …
- 1683
- Next Page »